MedPath

Participatory Design of Patient-centered Depression and Diabetes Care

Not Applicable
Completed
Conditions
Depression
Type 2 Diabetes Mellitus
Interventions
Behavioral: Education, encouragement
Behavioral: Education, encouragement, card sort
Registration Number
NCT02178176
Lead Sponsor
University of Pennsylvania
Brief Summary

The burden of diabetes is anticipated to grow yet the proportion of adults whose diabetes is controlled is decreasing over time. This project can have a significant public health impact because we are refining and pilot testing a primary-care based intervention aimed at improving patient engagement and function which are critical components of diabetes care and are associated with improved glycemic control, lower disease-related health-care expenditures, and reduced mortality.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
78
Inclusion Criteria
  1. 18 years and older
  2. a current diagnosis of Type 2 DM
  3. HbA1c 7%
  4. current prescription for an oral hypoglycemic agent
  5. able to communicate in English
  6. willing to give informed consent
Read More
Exclusion Criteria
  1. acutely suicidal or psychotic (patients will not be randomized and PI or physician covering for PI will be paged immediately)
  2. significant cognitive impairment at baseline (a total score on Mini-Mental State Examination (MMSE) 21)
  3. markedly shortened life expectancy (diagnosis of metastatic cancer, end-stage renal disease on dialysis, or NYHA Class III or IV congestive heart failure)
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Education, encouragementEducation, encouragement-
Education, encouragement, card sortEducation, encouragement, card sort-
Primary Outcome Measures
NameTimeMethod
Depression: nine-item Patient Health Questionnaire (PHQ-9)Baseline and 14 weeks
Glycemic control: hemoglobin A1cBaseline and 14 weeks
Adherence to oral hypoglycemic agents: Medication Event Monitoring SystemOver 14 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath